Curcumin: a natural substance with potential efficacy in Alzheimer’s disease

Curcumin: a natural substance with potential efficacy in Alzheimer’s disease

Pamela E Potter Department of Pharmacology, Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA Abstract: Curcumin is a component of turmeric, a spice used in many types of cooking. Epidemiological evidence suggesting that populations that eat food with a substantial am...

Full description

Bibliographic Details
Main Author:	Potter PE
Format:	Article
Language:	English
Published:	Dove Medical Press 2013-05-01
Series:	Journal of Experimental Pharmacology
Online Access:	http://www.dovepress.com/curcumin-a-natural-substance-with-potential-efficacy-in-alzheimerrsquo-a12950

Similar Items

Neuroinflammation in Alzheimer’s disease
by: Zhang FJ, et al.
Published: (2015-01-01)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
by: Zhang N, et al.
Published: (2018-10-01)

Olfactory dysfunction in Alzheimer’s disease
by: Zou YM, et al.
Published: (2016-04-01)

Role of berberine in Alzheimer’s disease
by: Cai Z, et al.
Published: (2016-10-01)

Targeting neuroinflammation in Alzheimer’s disease
by: Bronzuoli MR, et al.
Published: (2016-11-01)

Profile of gantenerumab and its potential in the treatment of Alzheimer’s disease [Corrigendum]
by: Novakovic D, et al.
Published: (2014-05-01)

Therapeutic Potential of Vitamin D and Curcumin in an Model of Alzheimer Disease
by: Abir Abdullah Alamro, et al.
Published: (2020-05-01)

Curcumin in Health and Diseases: Alzheimer’s Disease and Curcumin Analogues, Derivatives, and Hybrids
by: Eirini Chainoglou, et al.
Published: (2020-03-01)

RAB10: an Alzheimer’s disease resilience locus and potential drug target
by: Tavana JP, et al.
Published: (2018-12-01)

Magnetic resonance spectroscopy in Alzheimer’s disease
by: Graff-Radford J, et al.
Published: (2013-05-01)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
by: Tiwari S, et al.
Published: (2019-07-01)

Clinical neurorestorative progress in Alzheimer’s disease
by: Qiao L, et al.
Published: (2014-12-01)

WHAT’S IN CURCUMIN’S MIND? THE POTENTIAL ROLE OF CURCUMINOIDS IN THE TREATMENT OF ALZHEIMER’S DISEASE
by: Paola Marzullo
Published: (2021-03-01)

Cerebral small vessel disease and Alzheimer’s disease
by: Cai Z, et al.
Published: (2015-10-01)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
by: Jelcic N, et al.
Published: (2014-09-01)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
by: Kose Ozlece H, et al.
Published: (2018-07-01)

Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease
by: Gregory A Jicha, et al.
Published: (2010-03-01)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
by: Stuart J Thomas, et al.
Published: (2009-09-01)

The Potential of Curcumin and its Derivatives in the Treatment of Alzheimer’s Disease in Transgenic Animal Model
by: Wan-LunHuang, et al.
Published: (2018)

Ceruloplasmin and iron in Alzheimer&rsquo;s disease and Parkinson&rsquo;s disease: a synopsis of recent studies
by: Kristinsson J, et al.
Published: (2012-11-01)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
by: Yuan J, et al.
Published: (2013-05-01)

Liposome delivery systems for the treatment of Alzheimer’s disease
by: Ross C, et al.
Published: (2018-12-01)

What are the links between hypoxia and Alzheimer’s disease?
by: Lall R, et al.
Published: (2019-05-01)

Late onset Alzheimer’s disease in older people
by: Ahmet Turan Isik
Published: (2010-10-01)

Cerebral blood flow in Alzheimer&rsquo;s disease
by: Roher AE, et al.
Published: (2012-10-01)

Update on the use of memantine in Alzheimer&rsquo;s disease
by: Robert J van Marum
Published: (2009-03-01)

Personalizing the Care and Treatment of Alzheimer’s Disease: An Overview
by: Svob Strac D, et al.
Published: (2021-05-01)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease
by: Zhang M, et al.
Published: (2021-01-01)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
by: Klimova B, et al.
Published: (2017-10-01)

Activation of mTOR: a culprit of Alzheimer’s disease?
by: Cai Z, et al.
Published: (2015-04-01)

Rescuing apoptotic neurons in Alzheimer’s disease using wheat germ agglutinin-conjugated and cardiolipin-conjugated liposomes with encapsulated nerve growth factor and curcumin
by: Kuo YC, et al.
Published: (2015-04-01)

Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer’s disease: A systematic review and meta-analysis
by: Richard A Hansen, et al.
Published: (2008-06-01)

Removal of Aβ Oligomers from the Blood: A Potential Therapeutic System for Alzheimer’s Disease
by: Saito Y, et al.
Published: (2020-03-01)

Serum miR-128 Serves as a Potential Diagnostic Biomarker for Alzheimer’s Disease [Corrigendum]
by: Zhang M, et al.
Published: (2021-02-01)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
by: Cardoso BR, et al.
Published: (2013-05-01)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
by: Small JA, et al.
Published: (2020-04-01)

Advances with RNA interference in Alzheimer&rsquo;s disease research
by: Chen S, et al.
Published: (2013-02-01)

Optimal treatment of Alzheimer’s disease psychosis: challenges and solutions
by: Koppel J, et al.
Published: (2014-11-01)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
by: Çalık AN, et al.
Published: (2014-07-01)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
by: Ben Seltzer
Published: (2009-12-01)

Cannot write session to /tmp/vufind_sessions/sess_j56qhdmmem182qsd4nhttlt8l7